Biosimilars Adoption: Recognizing and Removing the RoadBlocks
Sarfaraz K Niazi College of Pharmacy, University of Illinois, Chicago, IL, 60612, USACorrespondence: Sarfaraz K Niazi, Tel +1-312-297-0000, Email niazi@niazi.comAbstract: Almost two decades since biosimilars arrived, we still await their broader adoption, as anticipated. The roadblocks to this adopt...
Main Author: | Niazi SK |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-04-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/biosimilars-adoption-recognizing-and-removing-the-roadblocks-peer-reviewed-fulltext-article-CEOR |
Similar Items
-
Biosimilars: Harmonizing the Approval Guidelines
by: Sarfaraz K. Niazi
Published: (2022-07-01) -
On the Regulatory Approval Pathway of Biosimilar Products
by: Jun Wang, et al.
Published: (2012-03-01) -
The Biosimilar Landscape: An Overview of Regulatory Approvals by the EMA and FDA
by: Ioana Gherghescu, et al.
Published: (2020-12-01) -
Scientific Rationale for Waiving Clinical Efficacy Testing of Biosimilars
by: Niazi S
Published: (2022-08-01) -
The Coming of Age of Biosimilars: A Personal Perspective
by: Sarfaraz K. Niazi
Published: (2022-04-01)